indazoles has been researched along with honokiol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukherji, M; Subhani, S; Vavilala, DT | 1 |
| Buabeid, M; Dhanasekaran, M; Dwyer, D; Fabbrini, M; Fujihashi, A; Govindarajulu, M; Lynd, T; Mohanakumar, KP; Moore, T; Neel, L; Ramesh, S; Shah, K; Smith, F | 1 |
2 review(s) available for indazoles and honokiol
| Article | Year |
|---|---|
HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Anthracyclines; Biphenyl Compounds; Cardiac Glycosides; Humans; Hypoxia-Inducible Factor 1; Indazoles; Lignans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Retinal Neovascularization; Vascular Endothelial Growth Factors | 2016 |
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Biphenyl Compounds; Dietary Supplements; Drug Delivery Systems; Enzyme Inhibitors; Glucosides; Humans; Hydrazines; Indazoles; Lignans; Neuroprotection; Phenols; Sirtuin 3 | 2021 |